Literature DB >> 1369166

Enhancing monoclonal antibodies and hybridoma cell lines.

S S Seaver.   

Abstract

We are interested in determining the range of variants present in a cell population that can actually be isolated. We have used subcloning and sublining to search for variants with increased antibody stability, increased cell line stability to freezing and defrosting, increased cell population viability, increased antibody production and the ability to grow in simpler media. This paper presents the case histories of several different hybridoma cell lines which required some property changed before they became production ready clones. We found that switching the class of an antibody from IgG3 to IgG1 did increase its stability, decrease its tendency to aggregate and allowed it to be used in a commercial diagnostic kit. We could isolate subclones that produced twice the level of antibody with a frequency of 1-3%. It was straight forward to isolate clones that were stable to freezing and defrosting or grew in a simpler media. We were not successful in increasing the maximum viability of a cell line. In conclusion, we have found that any population of hybridoma cells has natural variants with significantly enhanced properties that can be isolated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1369166     DOI: 10.1007/bf02521740

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  12 in total

1.  Methods for increasing monoclonal antibody production in suspension and entrapped cell cultures: biochemical and flow cytometric analysis as a function of medium serum content.

Authors:  C Heath; R Dilwith; G Belfort
Journal:  J Biotechnol       Date:  1990-07       Impact factor: 3.307

2.  Immobilization can improve the stability of hybridoma antibody productivity in serum-free media.

Authors:  G M Lee; B O Palsson
Journal:  Biotechnol Bioeng       Date:  1990-12-05       Impact factor: 4.530

Review 3.  Immunoglobulin class switching: molecular and cellular analysis.

Authors:  C Esser; A Radbruch
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

4.  Killing of human tumor cell lines by human monocytes and murine monoclonal antibodies.

Authors:  M D Lubeck; Y Kimoto; Z Steplewski; H Koprowski
Journal:  Cell Immunol       Date:  1988-01       Impact factor: 4.868

5.  Isolation of immunoglobulin class switch variants from hybridoma lines secreting anti-idiotope antibodies by sequential sublining.

Authors:  C E Müller; K Rajewsky
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

6.  The identification of monoclonal class switch variants by sib selection and an ELISA assay.

Authors:  G Spira; A Bargellesi; J L Teillaud; M D Scharff
Journal:  J Immunol Methods       Date:  1984-11-30       Impact factor: 2.303

7.  Isolation of heavy chain class switch variants of a monoclonal anti-DC1 hybridoma cell line: effective conversion of noncytotoxic IgG1 antibodies to cytotoxic IgG2 antibodies.

Authors:  P Parham; T J Kipps; F E Ward; L A Herzenberg
Journal:  Hum Immunol       Date:  1983-10       Impact factor: 2.850

8.  Hybridoma growth and antibody secretion in serum-supplemented and low protein serum-free media.

Authors:  J P Tharakan; A Lucas; P C Chau
Journal:  J Immunol Methods       Date:  1986-11-20       Impact factor: 2.303

9.  Isolation and characterization of anti-monosialoganglioside monoclonal antibody 19-9 class-switch variants.

Authors:  Z Steplewski; G Spira; M Blaszczyk; M D Lubeck; A Radbruch; H Illges; D Herlyn; K Rajewsky; M Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

10.  Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants.

Authors:  M S Kaminski; K Kitamura; D G Maloney; M J Campbell; R Levy
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

View more
  1 in total

1.  Selecting and designing cell lines for improved physiological characteristics.

Authors:  J R Birch; R C Boraston; H Metcalfe; M E Brown; C R Bebbington; R P Field
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.